Biotech Values

[DewDiligence]

Addendum re Teva’s propaganda campaign on generic Copaxone:

I should have included the link to #msg-45378265 in my prior post in this thread. #msg-45378265 is the post that takes Teva’s Bill Marth to task for telling Wall Street analysts that Copaxone can’t be characterized because it has 10,000,000,000,000,000,000,000,000,000 permutations.

What’s astonishing is that the analysts, to my knowledge, have never questioned this disingenuous assertion.